# Click Therapeutics

launched Rejoyn in April 2024, the first-and-only prescription digital therapeutic cleared by the FDA for the adjunctive treatment of major depressive disorder symptoms, and expanded it to Great Britain in June 2025.

Source: https://en.bioecon.ru/companies/click-therapeutics/
Updated: 2026-07-20

- Country: United States

## Technologies

- [Digital therapeutics](https://en.bioecon.ru/technology/digital-therapeutics/)